Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21872492 | 1.00 | EPHX1 (0.42) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL20822491 | 0.97 | EPHX1 (0.46) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL3838865 | 0.97 | EPHX1 (0.46) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL28997938 | 0.97 | EPHX1 (0.46) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL23058658 | 0.92 | DNM1 (0.38) | EPHX1LMNADNM1TSHRFDPS | |
| SCHEMBL23851320 | 0.92 | EPHX1 (0.50) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL24702390 | 0.92 | EPHX1 (0.50) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL23851606 | 0.92 | EPHX1 (0.50) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL22344693 | 0.92 | EPHX1 (0.50) | EPHX1OPRM1LMNADNM1ADH1B | |
| SCHEMBL25137857 | 0.92 | EPHX1 (0.50) | EPHX1OPRM1LMNADNM1ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109661229-B | Compounds and compositions for the treatment of cancer | 加利福尼亚大学董事会 | 2022-06-28 | — | — | CN | disclosed |
| EP-3373937-B1 | ANTI-CD22 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF | SCHERER TECHNOLOGIES LLC R P (US) | 2021-12-22 | — | — | EP | disclosed |
| US-20120328863-A1 | Silicone-Based Releasable Adhesive Composition, Sheet-Form Substrate Having Releasable Adhesive Layer Formed By Curing This Composition, And Use Of Such A Protective Film Or Fixing Sheet | DOW CORNING TORAY CO., LTD. (JP) | 2012-12-27 | — | — | US | disclosed |
| EP-2524954-A1 | RE-ADHERABLE SILICONE-BASED ADHESIVE COMPOSITION, SHEET-SHAPED BASE MATERIAL HAVING RE-ADHERABLE ADHESIVE LAYER OBTAINED BY CURING SAID COMPOSITION, AND USE OF SAID BASE MATERIAL AS PROTECTIVE FILM OR AFFIXING SHEET | Dow Corning Toray Co., Ltd. (JP) | 2012-11-21 | — | — | EP | disclosed |
| EP-0206621-A1 | Process for disproportionating silanes | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-12-30 | — | — | EP | disclosed |